Related Experiment Videos
IL-3 is produced by normal stroma in long-term bone marrow cultures
1Department of Cellular and Molecular Sciences, St. George's Hospital Medical School, London.
British Journal of Haematology
|July 1, 1995
Summary
Bone marrow stromal cells produce Interleukin-3 (IL-3), crucial for blood cell formation. This study developed a sensitive assay to detect IL-3 production, confirming its presence and identifying T cells as a likely source.
Area of Science:
- Hematology
- Immunology
- Cell Biology
Background:
- Interleukin-3 (IL-3) is vital for hematopoiesis, but its production by human bone marrow stromal cells in long-term cultures (LTBMC) has been difficult to detect.
- Previous studies using Northern blotting, bioassays, and limited RT-PCR failed to consistently demonstrate IL-3 production by stromal cells.
Purpose of the Study:
- To develop a sensitive bioassay for detecting IL-3 production by normal human stromal cells in LTBMC.
- To investigate the mechanism of IL-3 action and identify the source of IL-3 within the bone marrow stroma.
Main Methods:
- Developed a sensitive bioassay using cocultures of stromal cells with target bone marrow mononuclear cells (BMMC) or CD34+ cells in clonogenic assays.
- Utilized anti-IL-3 neutralizing antibodies and cell culture inserts to assess IL-3 dependency and cell contact.
- Confirmed IL-3 mRNA expression using reverse transcription-polymerase chain reaction (RT-PCR) and detected CD2 mRNA to identify T cells.
Main Results:
- Demonstrated IL-3 production in 32/34 LTBMC cultures using the developed bioassay.
- Showed that direct stroma:stem cell contact is not necessary for colony growth, indicating IL-3 diffusion.
- Detected IL-3 mRNA in 3/3 cases, and CD2 mRNA, suggesting T cells within the stroma are a likely source of IL-3.
Conclusions:
- Normal human bone marrow stromal cells produce IL-3, detectable with a sensitive bioassay.
- IL-3 likely acts via short-range diffusion at low levels, and T cells within the bone marrow stroma are probable producers.